[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11201908596WA - Mmlv reverse transcriptase variants - Google Patents

Mmlv reverse transcriptase variants

Info

Publication number
SG11201908596WA
SG11201908596WA SG11201908596WA SG11201908596WA SG 11201908596W A SG11201908596W A SG 11201908596WA SG 11201908596W A SG11201908596W A SG 11201908596WA SG 11201908596W A SG11201908596W A SG 11201908596WA
Authority
SG
Singapore
Prior art keywords
koll
pleasanton
suite
california
parkway
Prior art date
Application number
Inventor
Josephine Lee
Samuel Marrs
Geoffrey Mcdermott
Francesca Meschi
Luz Montesclaros
Katherine Pfeiffer
Joseph Francis Shuga
Jessica Michele Terry
Solongo B Ziraldo
Original Assignee
10X Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 10X Genomics Inc filed Critical 10X Genomics Inc
Publication of SG11201908596WA publication Critical patent/SG11201908596WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

1 • 4 N QC O O r•i 00 O 1-1 r•i O (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 01 November 2018 (01.11.2018) WIPO I PCT ~ill IIIIIIIIIImillIVIIIIIIIHo o olo Iniolioo Imo oimIE (10) International Publication Number WO 2018/200867 Al (51) International Patent Classification: C12N 9/12 (2006.01) Cl 2N 15/33 (2006.01) C12N 9/22 (2006.01) (21) International Application Number: PCT/US2018/029641 (22) International Filing Date: 26 April 2018 (26.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/490,492 26 April 2017 (26.04.2017) US (71) Applicant: 10X GENOMICS, INC. [US/US]; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). (72) Inventors: LEE, Josephine; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). MARRS, Sa- muel; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). MCDERMOTT, Geoffrey; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). MESCHI, Francesca; 7068 Koll Center Park- way, Suite 401, Pleasanton, California 94566 (US). MON- TESCLAROS, Luz; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94556 (US). PFEIFFER, Kather- ine; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). SHUGA, Joseph Francis; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). TERRY, Jessica Michele; 7068 Koll Cen- ter Parkway, Suite 401, Pleasanton, California 94556 (US). ZIRALDO, Solongo B.; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). (74) Agent: SCHULTZ, Jason; WILSON SONSINI GOODRICH & ROSATI, 650 Page Mill Road, Palo Alto, US 94304 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (54) Title: MMLV REVERSE TRANSCRIPTASE VARIANTS 100 104 106 FIG. 1 (57) : Disclosed herein, are compositions, methods, and kits comprising engineered reverse transcription enzymes that ex- hibit several desired properties such as thermal stability, processive reverse transcription, non-templated base addition, and template switching ability. The engineered reverse transcription enzymes described herein demonstrate unexpectedly higher resistance to cell lysate inhibition, greater ability to capture full-length mRNA transcripts, and demonstrate improved results in small reaction volumes as compared to other engineered reverse transcription enzymes. [Continued on next page] WO 2018/200867 Al MIDEDIMOMOIDEIRDERI001010111MIIIMERVOIMIE DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h))
SG11201908596W 2017-04-26 2018-04-26 Mmlv reverse transcriptase variants SG11201908596WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762490492P 2017-04-26 2017-04-26
PCT/US2018/029641 WO2018200867A1 (en) 2017-04-26 2018-04-26 Mmlv reverse transcriptase variants

Publications (1)

Publication Number Publication Date
SG11201908596WA true SG11201908596WA (en) 2019-11-28

Family

ID=63918723

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908596W SG11201908596WA (en) 2017-04-26 2018-04-26 Mmlv reverse transcriptase variants

Country Status (4)

Country Link
EP (2) EP4375376A3 (en)
CN (1) CN110637084A (en)
SG (1) SG11201908596WA (en)
WO (1) WO2018200867A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3752634T3 (en) * 2018-02-13 2022-10-24 Illumina Inc DNA Sequencing Using Hydrogel Beads / DNA sequencing using hydrogel beads
CN112442493A (en) * 2019-08-30 2021-03-05 广东菲鹏生物有限公司 Thermostable reverse transcriptase
WO2021119320A2 (en) 2019-12-11 2021-06-17 10X Genomics, Inc. Reverse transcriptase variants
CN111647576B (en) * 2020-06-24 2021-02-09 南京诺唯赞生物科技股份有限公司 Thermostable reverse transcriptase mutant and application thereof
CN112011596A (en) * 2020-09-11 2020-12-01 深圳华大因源医药科技有限公司 Method, solution and kit for simultaneously detecting multiple microbial genomes
WO2022232571A1 (en) * 2021-04-30 2022-11-03 10X Genomics, Inc. Fusion rt variants for improved performance
CN113355303B (en) * 2021-06-07 2023-06-16 中元汇吉生物技术股份有限公司 M-MLV reverse transcriptase mutant and application thereof
WO2022265965A1 (en) * 2021-06-14 2022-12-22 10X Genomics, Inc. Reverse transcriptase variants for improved performance
CN113817707B (en) * 2021-11-23 2022-02-22 中国医学科学院北京协和医院 Mutant recombinant reverse transcriptase and preparation method and application thereof
WO2023114473A2 (en) * 2021-12-16 2023-06-22 10X Genomics, Inc. Recombinant reverse transcriptase variants for improved performance

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7516694A (en) 1993-07-30 1995-02-28 Affymax Technologies N.V. Biotinylation of proteins
JP2004511211A (en) * 2000-05-26 2004-04-15 インヴィトロジェン コーポレーション Thermostable reverse transcriptase and its use
WO2007022045A2 (en) * 2005-08-10 2007-02-22 Stratagene California Mutant reverse transcriptase and methods of use
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
GB0806562D0 (en) * 2008-04-10 2008-05-14 Fermentas Uab Production of nucleic acid
WO2012149042A2 (en) * 2011-04-25 2012-11-01 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
CN114891871A (en) 2012-08-14 2022-08-12 10X基因组学有限公司 Microcapsule compositions and methods
US20140378345A1 (en) 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
EP3097190A2 (en) * 2014-01-22 2016-11-30 Life Technologies Corporation Novel reverse transcriptases for use in high temperature nucleic acid synthesis
JP6726659B2 (en) 2014-04-10 2020-07-22 10エックス ジェノミクス, インコーポレイテッド Fluidic devices, systems and methods for encapsulating and partitioning reagents and their applications
KR20230070325A (en) 2014-06-26 2023-05-22 10엑스 제노믹스, 인크. Methods of analyzing nucleic acids from individual cells or cell populations
CN106536756A (en) 2014-06-26 2017-03-22 10X基因组学有限公司 Analysis of nucleic acid sequences
WO2015200871A1 (en) 2014-06-26 2015-12-30 10X Genomics, Inc. Methods and compositions for sample analysis
EP4105337A1 (en) * 2014-09-09 2022-12-21 The Broad Institute, Inc. A droplet-based method and apparatus for composite single-cell nucleic acid analysis
US9580698B1 (en) * 2016-09-23 2017-02-28 New England Biolabs, Inc. Mutant reverse transcriptase

Also Published As

Publication number Publication date
EP3592847B1 (en) 2024-06-05
EP4375376A3 (en) 2024-08-14
CN110637084A (en) 2019-12-31
WO2018200867A1 (en) 2018-11-01
EP3592847A4 (en) 2021-05-05
EP3592847C0 (en) 2024-06-05
EP3592847A1 (en) 2020-01-15
EP4375376A2 (en) 2024-05-29

Similar Documents

Publication Publication Date Title
SG11201908596WA (en) Mmlv reverse transcriptase variants
SG11201901531TA (en) Regulation of gene expression using engineered nucleases
SG11201804836RA (en) Treatment of fibrosis
SG11201901371XA (en) Methods for the detection of genomic copy changes in dna samples
SG11201907566TA (en) Methods and compositions for labeling cells
SG11201810179RA (en) Novel crispr enzymes and systems
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201803983UA (en) Transformable tagging compositions, methods, and processes incorporating same
SG11201808751SA (en) T cell receptors
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201901563UA (en) De novo synthesized nucleic acid libraries
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201908787WA (en) Novel bispecific antigen binding molecules capable of specific binding to cd40 and to fap
SG11201903456WA (en) Piperidine derivatives as inhibitors of ubiquitin specific protease 7
SG11201407417VA (en) Encoding and reconstruction of residual data based on support information
SG11201810210UA (en) Engineered botulinum neurotoxins
SG11201806845VA (en) Moisturizing compositions and uses thereof
SG11201900746RA (en) Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions
SG11201909957TA (en) Engineered ligase variants
SG11201900753VA (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
SG11201407037UA (en) Catechol o-methyltransferase activity inhibiting compounds
SG11201804916PA (en) Three-dimensional polymer networks with channels situated therein
SG11201907420VA (en) Inhibition of smarca2 for treatment of cancer
SG11201804712PA (en) Biofuel
SG11201909419XA (en) Hydrogel for cell culture and biomedical applications